EMEA-002340-PIP01-18
Key facts
| Active substance |
nitrous oxide
|
| Therapeutic area |
Pain
|
| Decision number |
P/0217/2018
|
| PIP number |
EMEA-002340-PIP01-18
|
| Pharmaceutical form(s) |
Medicinal gas, liquefied
|
| Condition(s) / indication(s) |
Sedation
|
| Route(s) of administration |
Inhalation use
|
| Contact for public enquiries |
Società Italiana Carburo Ossigeno Spa SICO
Tel. +39 0382530059 E-mail: regulatory@gbpharma.it, cvino@gbpharma.it |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|